Euromed Pharma ensures its quality standards are in full alignment with the latest regulatory requirements, adhering to the specific needs of our partner companies and the guidelines set by regulatory bodies. We are actively involved with the European Medicines Verification Organisation (EMVO) to support the development of the European Medicines Verification System (EMVS). This initiative aims to authenticate medicines and improve patient safety, following the guidelines of the Falsified Medicines Directive (FMD) and the Delegated Regulation (DR), which specify safety feature requirements.
Our commitment to quality and safety is further evidenced by the authorizations we’ve received from AIFA (Italian Medicines Agency), the Ministry of Health, local health authorities (ATS/ASL), and our compliance with ISO 9001:2015 and ISO 13485:2016 certifications. These credentials enable us to ensure that our company procedures consistently meet or exceed the standards of current Good Manufacturing Practices (cGMP) and current Good Distribution Practices (GDP).
Our procedures include:
The role of Euromed Pharma in advancing medicinal traceability in Italy
Euromed Pharma, as a key player in the pharmaceutical industry, has developed a robust system for managing the Bollini labels with the Italian Mint (Istituto Poligrafico e Zecca dello Stato, IPZS), crucial for the Italian reimbursable system management. This initiative is part of a broader effort to ensure the traceability and authenticity of medicines throughout the entire distribution chain in Italy, from production or importation to delivery to the public.
Privacy Policy – Cookie Policy – Whistleblowing – Euromed Pharma a Petrone Group Company®